Enfusion (ENFN)
(Delayed Data from NYSE)
$8.81 USD
+0.11 (1.26%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $8.80 -0.01 (-0.11%) 5:18 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ENFN 8.81 +0.11(1.26%)
Will ENFN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ENFN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ENFN
Implied Volatility Surging for Enfusion (ENFN) Stock Options
Enfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say
ENFN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Radware (RDWR) Surpasses Q1 Earnings and Revenue Estimates
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
Other News for ENFN
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
FTV Capital Expands Internationally with Opening of London Office
Analysts Offer Insights on Technology Companies: NEXTracker, Inc. Class A (NXT), ON Semiconductor (ON) and Enfusion (ENFN)
Analysts Offer Insights on Technology Companies: Enfusion (ENFN) and WalkMe (WKME)